According to a recent news article from Mesothelioma Research News, a new study involving what is known as the WT1 protein has been shown to have promising results in the treatment of malignant mesothelioma using chemotherapy drugs. There is a big focus on improving the efficacy of chemotherapy drugs, because surgical alternatives are very invasive and often result in significant complications for patients who undergo these procedures.
This study focused on malignant pleural mesothelioma (MPM). MPM is the type of cancer where the malignant tumors first appear in the lungs as oppose to the patient’s abdomen or chest. However, it is important to understand that, while the tumor may start in the lungs, the cancer can and often does quickly spread to other areas of the body where it does a tremendous amount of damage. Continue reading